Evidence map›Paper›PMID 32072274›Full record

ArticleCurrent microbiology2020

Oxytropis glabra DC. Inhibits Biofilm Formation of Staphylococcus epidermidis by Down-Regulating ica Operon Expression.

Xiaopu Ren, Lijun Wang, Wei Chen

Abstract read
PubMed Publisher
In one paragraph

Article in Current microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Biofilm Research in Bovine Mastitis.Frontiers in veterinary science · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Xiaopu RenKey Laboratory of Protection & Utilization of Biological Resources in Tarim Basin, Xinjiang Production & Construction Group, Tarim University, Alar, China.
Lijun WangKey Laboratory of Protection & Utilization of Biological Resources in Tarim Basin, Xinjiang Production & Construction Group, Tarim University, Alar, China.
Wei ChenKey Laboratory of Protection & Utilization of Biological Resources in Tarim Basin, Xinjiang Production & Construction Group, Tarim University, Alar, China. chenwei_alar@126.com.
Tarim University · CNXinjiang Production and Construction Corps · CN

Funding

Excellent Young Talents Fund Program of Higher Education Institutions of Anhui Province (CN) Grant NCET-11-1071Society of the Friendly Sons of St. Patrick for the Relief of Emigrants from Ireland (US) Grant 2009JC07the National Science Foundation of China Grant 31260026
6 · The paper itself

Abstract

Staphylococcus epidermidis is one of the main causes of medical device-related infections and bovine mastitis owing to its biofilm-forming abilities. Oxytropis glabra DC. is one of the most widespread Fabaceae species and used as a Chinese herbal formulation in Western China. Our research investigated the effects of O. glabra on the biofilm formation of S. epidermidis and the possible inhibiting mechanism. The biofilm-forming reference strain, S. epidermidis SE-1 (ATCC 35,984), was employed as a model and semi-quantitative biofilm assay was performed to evaluate the antibiofilm activity of O. glabra. The exopolysaccharides (EPS) production and expression of ica operon were studied to explore the possible antibiofilm mechanism using thin-layer chromatography and quantitative real-time PCR assay, respectively. The results obtained indicated that O. glabra decoction at 7.5 mg mL

Indexed as

OxytropisBiofilmsDown-RegulationOperonPlant ExtractsStaphylococcus epidermidisPlant Extracts

Identifiers

PMID32072274
OpenAlexW3008224747

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.